Goldman Sachs’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
|
|||||
|
2025
Q1 | $16.6M | Buy |
|
|||||
|
2024
Q4 | $17.6M | Buy |
|
|||||
|
2024
Q3 | $16.8M | Sell |
|
|||||
|
2024
Q2 | $13M | Buy |
|
|||||
|
2024
Q1 | $9.51M | Buy |
|
|||||
|
2023
Q4 | $8.31M | Sell |
|
|||||
|
2023
Q3 | $6.12M | Buy |
|
|||||
|
2023
Q2 | $7.51M | Sell |
|
|||||
|
2023
Q1 | $9.03M | Buy |
|
|||||
|
2022
Q4 | $7.12M | Sell |
|
|||||
|
2022
Q3 | $7.58M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $40K | Hold |
|
|||||
|
2020
Q2 | $57K | Hold |
|
|||||
|
2020
Q1 | $23K | Sell |
|
|||||
|
2019
Q4 | $26K | Sell |
|
|||||
|
2019
Q3 | $202K | Sell |
|
|||||
|
2019
Q2 | $1.12M | Buy |
|
|||||
|
2019
Q1 | $196K | Buy |
|
|||||
|
2018
Q4 | $179K | Buy |
|
|||||
|
2018
Q3 | $212K | Sell |
|
|||||
|
2018
Q2 | $295K | Sell |
|
|||||
|
2018
Q1 | $468K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.58M | Buy |
|
|||||
|
2017
Q1 | $807K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|